Suggestions
Angela Myers
Head of Gene Editing & Novel Modalities at MilliporeSigma
Angela Myers is a prominent figure in the field of gene editing and cell & gene therapy manufacturing, with a focus on technology development and contract manufacturing. She has a strong background in leading business initiatives and driving strategy in the healthcare industry, particularly in consulting, strategy development, and organizational change. Angela's educational background includes a Bachelor of Arts in Government from Harvard University. She currently serves as the Head of Gene Editing and Novel Modalities at MilliporeSigma, having previously held key positions such as Head of Strategy & Communications and Head of CEO Office within the same organization. Prior to her current role, she worked as a Project Leader at The Boston Consulting Group and as a Research Associate at Harvard Business School.